title: Balancing access and evaluation in the approval of new cancer drugs.
authors.affiliation: Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892-1156, USA. fmiller@nih.gov
authors.forename: Franklin G
authors.initials: FG
authors.lastname: Miller
authors.forename: Steven
authors.initials: S
authors.lastname: Joffe
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017277:Drug Approval / Q000458:organization & administration*; D017598:Efficiency, Organizational; D006297:Health Services Accessibility; D006801:Humans; D010344:Patient Advocacy; D011640:Public Policy; D016032:Randomized Controlled Trials as Topic; D012945:Social Values; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents